Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double‐blind trial

Alimentary Pharmacology & Therapeutics

Volumn 9, Issue 2, 1995, Pages 127-135

  LAINE, L ^a   COMINELLI, F ^a   SLOANE, R ^a   CASINI RAGGI V ^a   MARIN SORENSEN M ^b   WEINSTEIN, W M ^b  

^a UCLA Schools of Medicine ^*

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETODOLAC; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM INJURY; DIGESTIVE SYSTEM ULCER; DOUBLE BLIND PROCEDURE; ENDOSCOPY; FEMALE; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN EXPERIMENT; INFECTION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RANDOMIZED CONTROLLED TRIAL; STOMACH MUCOSA;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOUBLE-BLIND METHOD; ETODOLAC; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFLAMMATION; MIDDLE AGED; NAPROXEN; PROSTAGLANDINS; STOMACH ULCER;

EID: 0028965818     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.1995.tb00361.x     Document Type: Review

References (41)

1. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons
2. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States: Effect of age, race, and socioeconomic status
3. Effect of treatment of Helicobacter pylori infection on the long‐term recurrence of gastric or duodenal ulcer: a randomized controlled study
4. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer
5. Evaluating drugs after their approval for clinical use
6. Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy
7. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti‐inflammatory drug use
8. Frequency of gastroduodenal lesions in asymptomatic patients on chronic aspirin or nonsteroidal anti‐inflammatory drug therapy
9. Nonsteroidal antiinflammatory drug‐associated gastric ulcers do not require Helicobacter pylori for their development
10. Helicobacter pylori‐negative gastric ulcer
11. Long‐term nonsteroidal anti‐inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori
12. Nonsteroidal anti‐inflammatory drugs and peptic ulcer disease
13. A randomized, double‐blind comparison of placebo, etodolac and naproxen on gastrointestinal injury and prostaglandin production
14. Endoscopic evaluation of etodolac and naproxen and their relative effects on gastric and duodenal prostaglandins
15. A double‐blind gastroscopic evaluation of the effects of etodolac and naproxen on the gastrointestinal mucosa of rheumatic patients
16. Effect on gastric and duodenal mucosal prostaglandins of repeated intake of therapeutic doses of naproxen and etodolac in rheumatoid arthritis
17. International experience with etodolac therapy for rheumatoid arthritis: an interim report of comparative efficacy
18. Double‐blind comparison of etodolac and naproxen in the treatment of rheumatoid arthritis
19. Effectiveness of etodolac (‘Lodine’) compared with naproxen in patients with acute gout
20. Hypersensitive prostaglandin and thromboxane response to hormones in rabbit colitis
21. Correlation of mucosal histology and aspirin intake in chronic gastric ulcer
22. Histology of alcoholic hemorrhagic ‘gastritis’. A prospective evaluation
23. The histology of gastric erosions in patients taking non‐steroidal anti‐inflammatory drugs (NSAIDs): a prospective study (abstract)
24. Chronic gastritis‐a pathogenic approach
25. Chemical gastritis and Helicobacter pylori related gastritis in patients receiving non‐steroidal anti‐inflammatory drugs: Comparison and correlation with peptic ulceration
26. Reflux gastritis: distinct histopathologic entity
27. Stomach and proximal duodenum: Inflammatory and miscellaneous disorders
28. Histological study of the effects of three anti‐inflammatory preparations on the gastric mucosa
29. Effect on gastric and duodenal mucosal prostaglandins of repeated intake of therapeutic doses of naproxen and etodolac in rheumatoid arthritis
30. A prospective randomized study of the injurious effects of aspirin and naproxen on the gastroduodenal mucosa in patients with rheumatoid arthritis
31. Iatrogenic Campylobacter pylori infection is a cause of epidemic achlorhydria
32. Effect of Helicobacter pylori infection on the severity of gastroduodenal mucosal injury after NSAI acute administration of naproxen or aspirin to normal volunteers
33. Misoprostol Study Group. Helicobacter pylori infection and development of gastric or duodenal ulcer in arthritic patients receiving chronic NSAID therapy
34. Interrelationships between Helicobacter pylori infection, nonsteroidal antiinflammatory drugs and gastroduodenal disease: a prospective study in healthy volunteers
35. Gastric mucosal prostaglandin synthesis in the presence of Campylobacter pylori in patients with gastric ulcers and non‐ulcer dyspepsia
36. Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non‐steroidal anti‐inflammatory drugs
37. Gastroduodenal mucosal prostaglandin generation in patients with Helicobacter pylori before and after treatment with bismuth subsalicylate
38. 4 generation associated with H. pylori colonization
39. 2 in gastric mucosa of children with Helicobacter pylori gastritis: relation to thickness of mucus gel layer
40. Gastric and duodenal mucosal prostaglandin concentrations in gastric or duodenal ulcer disease: relation‐ships with demographics, environmental, and histological features, including Helicobacter pylori
41. Prevalence of Helicobacter pylori infection and its effect on symptoms and non‐steroidal anti‐inflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis